Barclays’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
68,551
+18,156
| +36% | +$114K | ﹤0.01% | 3113 |
|
|
2025
Q1 | $295K | Sell |
50,395
-22,330
| -31% | -$131K | ﹤0.01% | 3131 |
|
|
2024
Q4 | $598K | Buy |
72,725
+11,715
| +19% | +$96.3K | ﹤0.01% | 2948 |
|
|
2024
Q3 | $544K | Buy |
61,010
+43,897
| +257% | +$391K | ﹤0.01% | 2943 |
|
|
2024
Q2 | $129K | Sell |
17,113
-8,281
| -33% | -$62.4K | ﹤0.01% | 3256 |
|
|
2024
Q1 | $199K | Sell |
25,394
-12,775
| -33% | -$100K | ﹤0.01% | 3340 |
|
|
2023
Q4 | $338K | Buy |
38,169
+33,295
| +683% | +$295K | ﹤0.01% | 3234 |
|
|
2023
Q3 | $43K | Sell |
4,874
-22,978
| -83% | -$203K | ﹤0.01% | 3655 |
|
|
2023
Q2 | $344K | Sell |
27,852
-6,565
| -19% | -$81.1K | ﹤0.01% | 2817 |
|
|
2023
Q1 | $320K | Sell |
34,417
-2,102
| -6% | -$19.5K | ﹤0.01% | 2907 |
|
|
2022
Q4 | $384K | Sell |
36,519
-5,525
| -13% | -$58.1K | ﹤0.01% | 2743 |
|
|
2022
Q3 | $762K | Sell |
42,044
-142
| -0.3% | -$2.57K | ﹤0.01% | 2309 |
|
|
2022
Q2 | $598K | Sell |
42,186
-17,511
| -29% | -$248K | ﹤0.01% | 2454 |
|
|
2022
Q1 | $1.31M | Buy |
+59,697
| New | +$1.31M | ﹤0.01% | 2100 |
|